SOURCE: Atmospheric Glow Technologies, Inc.

October 04, 2007 09:00 ET

AGT Awarded NIH Commercialization Assistance

KNOXVILLE, TN--(Marketwire - October 4, 2007) - Atmospheric Glow Technologies, Inc. (OTCBB: AGWT) announced today that the company has been competitively chosen to participate in the National Institutes of Health Commercialization Assistance Program (NIH-CAP) to help bring additional applications of its patented plasma technology to market. Now in its fourth year, the program is designed to assist some of the most promising life science companies nationwide to commercialize their technologies. NIH-CAP is managed and executed by the Larta Institute and funded by the NIH.

"Larta Institute's experienced and expert network is available to innovators in the NIH Commercialization Assistance Program as a great launch vehicle for the dynamic life sciences marketplace," said Rohit Shukla, Larta Institute CEO. "As managers of this program, we're committed to uncovering and successfully introducing market innovations from companies like Atmospheric Glow Technologies, thus enhancing the lives of people everywhere."

Only a select number of NIH SBIR Phase II grantees will participate over the next several months in the program comprised of training workshops, individual mentoring and consulting sessions, and public forums in which companies present their technologies to the investment community, potential strategic partners and licensees.

"We're honored to be chosen for NIH-CAP and look forward to fully capitalizing on the commercialization concepts and contacts generated through this select program," said Dr. Kimberly Kelly-Wintenberg, AGT President, COO and Co-Founder.

"AGT is currently seeking strategic partners for our plasma technology in the areas of medical device sterilization, disinfection of food and other agricultural products and air purification, among others," added Scott McDonald, AGT CEO.

About Larta Institute

Larta Institute has become known in its 14-year history for innovative programs that connect people and drive innovation. It develops and operates technology commercialization programs for its clients, which include the National Institutes of Health, the Advanced Technology Program of the Department of Commerce's NIST, government-supported programs from Canada, New Zealand, Korea, Taiwan, Israel, and many other countries. It also works closely with universities, principally through a consortium of technology transfer officers which it started in 2003, Network T2. Its conferences, including Project T2 and the Venture Forum, have attracted the attention and participation of leading companies and investors throughout the U.S. The Venture Forum has absorbed Project T2 to form the largest and most effective conference devoted to early-stage innovations in the country. Supporters and sponsors of the Institute include the Kauffman Foundation, premier law firms, Fortune 1000 companies, investors and governments. For more information, please visit

About Atmospheric Glow Technologies, Inc.

AGT is a market-driven science and engineering company focused on realizing the commercial potential of OAUGDP® technology, a proprietary method of creating plasma chemistry in air at atmospheric pressure. Management believes that OAUGDP® is an exciting breakthrough technology offering capabilities that other plasma technologies do not provide. AGT's technology has been the recipient of numerous federal contracts, grants and recognition awards. Additional information is available at

Statements in this release that are not historical facts are forward-looking statements made pursuant to the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. In addition, words such as "believes," "anticipates," "expects," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievement of events of the company, or events, or timing of events, relating to the company to differ materially from any future results, performance, or achievements of the forward-looking statements. The company cannot assure that it will be able to anticipate or respond timely to the changes, which could adversely affect its operating results in one or more fiscal quarters. Results of operations in any past period should not be considered indicative of results to be expected in future periods. Fluctuations in operating results may result in fluctuations in the price of the company's securities.

Contact Information

  • Contact:

    W. Scott McDonald
    Phone: 865-777-3776 ext. 223